David Lyden

ORCID: 0000-0003-0193-4131
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Extracellular vesicles in disease
  • Cancer Cells and Metastasis
  • Immune cells in cancer
  • MicroRNA in disease regulation
  • Ferroptosis and cancer prognosis
  • Angiogenesis and VEGF in Cancer
  • Glioma Diagnosis and Treatment
  • Mesenchymal stem cell research
  • Heat shock proteins research
  • Cancer, Hypoxia, and Metabolism
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Cytokine Signaling Pathways and Interactions
  • Hematopoietic Stem Cell Transplantation
  • Neuroblastoma Research and Treatments
  • Endoplasmic Reticulum Stress and Disease
  • Cancer Research and Treatments
  • Cell Adhesion Molecules Research
  • Caveolin-1 and cellular processes
  • RNA Interference and Gene Delivery
  • Circular RNAs in diseases
  • Immune Cell Function and Interaction
  • Lymphatic System and Diseases
  • Chemokine receptors and signaling

Children's Cancer and Blood Foundation
2016-2025

Cornell University
2016-2025

Weill Cornell Medicine
2016-2025

Memorial Sloan Kettering Cancer Center
2012-2024

Universidade Nova de Lisboa
2016

Neurological Surgery
2013

National Eye Institute
2013

University of California, San Francisco
2012

University of California, Los Angeles
2011

Champalimaud Foundation
2011

About 50% of cancer patients receive radiation therapy. Here we investigated the hypothesis that tumor response to is determined not only by cell phenotype but also microvascular sensitivity. MCA/129 fibrosarcomas and B16F1 melanomas grown in apoptosis-resistant acid sphingomyelinase (asmase)-deficient or Bax-deficient mice displayed markedly reduced baseline endothelial apoptosis grew 200 400% faster than tumors on wild-type microvasculature. Thus, a homeostatic factor regulating...

10.1126/science.1082504 article EN Science 2003-05-15

Colon cancer stem cells are believed to originate from a rare population of putative CD133+ intestinal cells. Recent publications suggest that small subset colon expresses CD133, and only these capable tumor initiation. However, the precise contribution tumor-initiating in mediating metastasis remains unknown. Therefore, temporally spatially track expression CD133 adult mice during tumorigenesis, we generated knockin lacZ reporter mouse (CD133lacZ/+), which is driven by endogenous promoters....

10.1172/jci34401 article EN Journal of Clinical Investigation 2008-05-01

Tyrosine kinase receptors for angiogenic factors vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) are expressed not only by cells but also subsets of hematopoietic stem (HSCs). To further define their role in the regulation postnatal hematopoiesis vasculogenesis, VEGF Ang-1 plasma levels were elevated injecting recombinant protein or adenoviral vectors expressing soluble VEGF165, matrix-bound VEGF189, into mice. induced a rapid mobilization HSCs receptor (VEGFR)2+...

10.1084/jem.193.9.1005 article EN The Journal of Experimental Medicine 2001-04-30

Significance Increasing evidence suggests that extracellular vesicles (EVs) can transfer genetic material to recipient cells. However, the mechanism and role of this phenomenon are largely unknown. Here we have made a remarkable discovery: EVs harbor full mitochondrial genome. These in turn their mtDNA cells with impaired metabolism, leading restoration metabolic activity. We determined hormonal therapy induces oxidative phosphorylation-deficient breast cancer cells, which be rescued via...

10.1073/pnas.1704862114 article EN Proceedings of the National Academy of Sciences 2017-10-11
Coming Soon ...